Triple #22125

high Confidence

Knowledge triple

CTLA-4_inhibitor

Immune checkpoint inhibitors

Level 11

produces

Therapeutic relationship

significant_clinical_response

Clinical response

Level 12

Original triple: Immunotherapy with PD-1/PD-L1/CTLA-4 inhibitors#produced#significant clinical responses

Evidence and Confidence

Confidence: high
Evidence Strength: clinical
Condition Dependency: RCC patients
Fact or Inference: Fact

Clinical Relevance

Clinical Relevance: treat

Other Info

PMID: 38736105
Knowledge Particle: KP4
Value Leadboard: 7
Gene Symbol: PDCD1/CD274/CTLA4
Disease: RCC